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ABSTRACT 
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Medical University’s clinics with the established diagnosis of diabetic nephropathy 
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The purpose of this work is to evaluate the diagnostic capabilities of the dy-
namic scintigraphy method in determining the nature of kidney function disorders 
in patients with diabetes mellitus. 
In the course of the study, we conducted: kidney scintigraphy in dynamic 
mode, the study of the possibilities of the method of dynamic kidney scintigraphy in 
assessing the state of the kidneys in patients with diabetes mellitus. 
Scope: medical institutions. 
Cost-effectiveness/significance of the work: solving a complex range of di-
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Introduction 
 
Backgrounds 
Diabetes mellitus (DM) is a common socially significant disease that is char-
acterized by multiple organ damage. According to experts from the World Health 
Organization (WHO) the total number of patients with all forms of diabetes nowa-
days is about 425 million people. Diabetes is anticipated to become the seventh lead-
ing cause of death in the world by 2030 [1]. 
A specific complication of diabetes mellitus is diabetic nephropathy (DN) and 
occupies a leading position in the structure of patients with end-stage renal disease 
(ESRD) which is required extracorporeal method of treatment (program 
hemodialysis, kidney transplantation) and is one of the most expensive areas of 
health care worldwide [2]. DN is usually associated with hypertension and increased 
cardiovascular morbidity and mortality. The statistics are significantly worse for 
people with type 1 or 2 diabetes who have developed DN than without it. In the 
structure of mortality of patients with DM in Russia, due to ESRD of DN is the third 
most common cause of passing in patients with type 1 diabetes (7.1%) and the 
seventh – in patients with type 2 diabetes (1.8%) [3]. 
The DN screening carried out within the framework of the Saint Vincent 
Declaration incorporates common clinical urine analysis, a study of urine for the 
presence of microalbuminuria (MA), and the determination of non–selective 
proteinuria [4]. This allows to diagnose DN at the MA stage. However, some of 
DM’s patients with normoalbuminuria (NA) have progressive renal failure [5]. In 
this regard, the problem of determining the structural and functional changes of the 
kidney which are still reversible, becomes urgent. 
Radiation diagnostic methods are broadly utilized in the research of uroneph-
rology, such as X-ray, CT, and MRI [6]. These methods are less informative than 
radio-nuclide diagnostic methods and ultrasound. Ultrasound dopplerography is of-
14 
ten used to evaluate kidney vessels, which is extremely important in DM [7]. How-
ever, when performing an ultrasound at the initial stages of DN development, struc-
tural and anatomical changes in the renal parenchyma may not be determined relia-
bly [8]. However, radionuclide methods may reflect the functional state of organs by 
evaluating such parameters as the time of maximum accumulation of radiopharma-
ceutical RP (Tmax), the half-time of RP (T1/2) and the glomerular filtration rate (GFR), 
are regarded as methods of early registration of renal dysfunction, even at the pre-
clinical stage of development of pathological changes. Meanwhile, only a small 
number of studies are devoted to the use of the scintigraphy method to assess the 
functional state of the kidneys in patients with DM. 
In spite of the relevance of these studies in Nephrology, comparative data of 
radionuclide investigate methods in evaluating the state of the kidneys in patients 
with diabetes are not available. 
Thus, at the moment, the problem of a single guide for different types of DM 
with DN is still not solved. One of the most urgent and vital issues of modern nuclear 
medicine, which has not been completely solved at the world level, is the study of 
the latest methodological approaches to DN with different types of DM. 
The solution of a complex range of problems in the diagnosis of DN with DM 
should reduce the socio-economic burden on the population of various countries and 
essentially improve the quality of life of patients. 
 
Purpose of research. 
Evaluation of the diagnostic capabilities of the dynamic renal scintigraphy 
method for setting the nature of renal dysfunction in patients with DM 
 
Task of research. 
1. To study the results of dynamic renal scintigraphy in assessing the functional 
state of the kidneys in patients with DM depending on the severity of diabetic 
nephropathy; 
15 
2. Compare the results of dynamic renal scintigraphy with creatinine levels as a 
reference method for evaluating the glomerular filtration rate in a comparative 
aspect; 
3. Improves the algorithm for diagnosing kidney status in patients with diabetes 
mellitus. 
 
Scientific novelty. 
1. For the first time, a comprehensive comparative clinical and instrumental ap-
praisal of the kidney condition in patients with distinctive types of diabetes mellitus 
was performed. 
2. For the first time, based on the assessment of the results of radiation investi-
gate methods, an elective method of radiation diagnostics for assessing the func-
tional state of the kidneys in patients with DM is proposed, including the use of 
dynamic renal scintigraphy to assess the filtration function of the kidneys. 
 
Personal contribution of the author. 
The author's personal contribution consists in setting research objectives, de-
veloping experimental methods to solve them, directly participating in all experi-
mental and clinical studies, reviewing research results, and preparing for publication. 
All processing, analysis and interpretation of the obtained results is performed by 
the author personally. 
 
Implementation of results in practice. 
The results of the clinical study have been implemented in the practical work 
of the department of radionuclide diagnostics of the Federal State Budgetary Educa-
tional Institution of Higher professional education "Siberian State Medical Univer-
sity" of the Ministry of Health of the Russian Federation. It is used in the teaching 
process at the department of radionuclide diagnostics. 
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Annual stages. 
1-st year – approval of the thesis topic with the head of the graduated qualifying 
work (GQW), the study of the necessary literature on the research topic, conducting 
radionuclide, and scintigraphy studies of patients, preparation of thesis chapters "In-
troduction" and "Literature review". 
2-nd year – completion of a set of clinical materials, obtaining final results, 
processing, and analysis, formulation of research conclusions, implementation of re-
sults in clinical practice, the final design of the thesis. Thesis defense. 
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Chapter 1. Literature review 
 
1.1 Diabetes Mellitus 
 
According to the definition of the International Expert Committee (ICE) on 
the diagnosis and classification of diabetes mellitus (DM) from 1997, diabetes melli-
tus is a group of metabolic (exchange) diseases characterized by hyperglycemia, 
which is the result of damage to the secretion of insulin, the action of insulin, or a 
combination of these two factors [9, 10, 11, 12].  
Diabetes mellitus occupies a dramatic role in world medicine as a disease 
associated with a high level of human and economic resources expenditure and will 
become the 7 main causes of death worldwide by 2030 [9, 10, 11, 14, 13]. Since 
chronic hyperglycemia, which develops in DM, is accompanied by the development 
of a large number of complications and multi-organ damage, primarily from kidneys, 
the heart, nerves, blood vessels, and eyes [15]. According to WHO experts, "diabetes 
mellitus is a problem of all peoples and ages", due to its wide geographical spread, 
an exceptionally rapid increase in morbidity, early disability in patients of working 
age and high mortality from complications that gradually progress after the occur-
rence, significantly reducing the quality of life and shortening its duration [16]. 
At present, the number of patients suffering from diabetes in the world is 
about 425 million people, and agreeable forecasts, the number of patients will grow 
to 629 million by 2045 [1]. According to the IDF (International Diabetes Federa-
tion), it is estimated that at least 212.4 million people worldwide, or half (50%) of 
all people with diabetes, are unaware of their illnesses [1, 11]. The study has shown 
that in 2012, additional health care costs due to undiagnosed diabetes amounted to $ 
33 billion per year [17, 1]. And in 2017, 4 million people die worldwide due to DM, 
which is equivalent to one death every 8 seconds [1]. 
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The age group of patients with DM ranges from 20 to 79 years [10, 1]. But 
also in 2017, there were more than 96,000 new cases of type 1 diabetes in children 
[1]. 
As of 01.01.2019, there were 4.58 million DM patients in Russia. Of these, 
26,373 children, 9,972 adolescents, and 219,857 adults suffered from type 1 diabe-
tes. And type 2 diabetes affected 913 children, 299 adolescents, and 4,237,291 adults 
[15]. In conformity with forecasts, the number of new patients with DM in the Rus-
sian Federation will increase to 4.4 million by 2030 [18]. 
As already mentioned, diabetes is a huge medical, social and economic prob-
lem [19, 20]. in 2017, the cost of health care due to diabetes reached 727 billion US 
dollars, and since 2013, it has increased by 32.6% of the total health care costs for 
treating the adult population in the world [1]. At the same time, costs in the United 
States of America amounted to 348 billion US dollars, that is, almost half of all costs 
for DM in the world, in China-110 billion US dollars [1]. In total, the patient's stay 
in the hospital for lower limb amputation totaled us $ 16.2 million [21].  
19 
1.2 Diabetic nephropathy 
 
Diabetic kidney disease (DKD), or chronic kidney disease (CKD) in individ-
uals with diabetes mellitus (DM), also called diabetic nephropathy (DN), is one of 
the most frequent and severe chronic complications of DM resulting from microvas-
cular lesions in the renal glomeruli and tubules, the end stage of which is character-
ized by the development of chronic kidney disease (CKD) [22, 23, 1, 2]. However, 
due to the strong association between DN and cardiovascular diseases, the vast ma-
jority of patients with DN die even before the progression of ESRD, due to cardio-
vascular diseases [1, 2]. 
 
1.2.1 Epidemiology and frequency of DN development 
 
Information on the frequency of diabetic nephropathy is variable and de-
pends on the age and length of the illness in which it debuted. Recent epidemiolog-
ical studies have shown that the frequency of DN ranges from 25 to 40% in patients 
with type 1 diabetes and from 5 to 40% in patients with type 2 diabetes. In addition, 
20% to 30% of patients with type 1 diabetes have microalbuminuria (MA) on aver-
age after 5-10 years since DM is detected, but it can also be present in 20% of pa-
tients at the beginning of type 2 diabetes [24]. It is reported that the overall frequency 
of end-stage CKD is 4-17% in 20-30 years after the onset of type 1 diabetes [25, 26, 
27]. Thus, in people with type 1 or type 2 diabetes, complications develop earlier, 
and, accordingly, screening should begin early in the course of diabetes [28]. Non-
albuminuric diabetic nephropathy (NADN) has been less studied disease, but re-
cently, Thorn et al. reported that 2% of patients with type 1 diabetes have NADN 
[29]. 
According to data from the UK, one fifth of people with diabetes and from 
the US, 40% of people with diabetes develop chronic kidney disease, while 19% 
show signs of stage 3 or higher [1]. Combined data from 54 countries show that 
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more than 80% of end-stage renal disease is caused by diabetes. The proportion of 
CKD caused by diabetes varies from 12 to 55%. The prevalence of CKD is also up 
to 10 times higher in people with DM than in people without it [1]. 
A study by Nichols G. A. et al. (2011) presented that the progression of dia-
betic nephropathy essentially increases the medical costs of treating patients diag-
nosed with diabetic nephropathy. The authors studied a sample of almost 8,000 pa-
tients with DN and found that restorative costs expanded by 37% when nephropathy 
advanced from normoalbuminuria to microalbuminuria, and by another 41% when 
it advanced from microalbuminuria to macroalbuminuria [30]. 
Thus, the long-term asymptomatic course of DN, the high mortality rate of 
patients with end-stage CKD, as well as the high financial costs of treating this cat-
egory of patients make the advancement of methods for early determination of DN 
increasingly relevant in the present time [30, 31, 32]. 
 
1.2.2 Pathogenesis of DN 
 
The development of diabetic kidney disease (DKD) depends on the duration 
of diabetes mellitus (DM), the severity of metabolic disorders, concomitant hyper-
tension, and genetic factors. DN is caused by changes in the basement membrane, 
which lead to a decrease in its negative charge and an increase in the size of the 
pores. High blood glucose levels and blood pressure increase simultaneously with 
intra-glomerular pressure. As a result, albumin filtration increases, initially in the 
form of albuminuria (MA) from 30 to 300 mg / 24 hours, which is equivalent to 30 
to 300 mg / g of creatinine in a random urine sample (albumin-to-creatinine ratio 
[A/CR], 3-30 mg/mmol), and then explicit proteinuria (PO)>300 mg/24 hours) [34]. 
Over time, this leads to glomerular hyalinosis (diffuse or nodular glomerulosclero-
sis), intra-tissue fibrosis, and the development of kidney failure. In addition, the 
presence of kidney failure increases the risk of heart disease and medical expenses 
in patients with DM [35, 35]. 
21 
For diabetic kidney disease are significant certain risk factors in the preven-
tion or delay of CKD and for personalized treatment strategies. Those factors divided 
on non-modified and modified are: 
Non-modifiable   
• Genetic factor 
• Male sex 
• Age the onset of diabetes from 5 
to 15 years 
• Long duration of diabetes 
• Ethnicity 
• Increasing age 
 
Modifiable  
• Poor glycemic control 
• Hypertension 
• Lipid abnormalities 
• Obesity 
• Metabolic syndrome 
• Insulin resistances  
• Low-grade inflammation 
• Birth weight 
 
1.2.3 Classification and formulation for the diagnosis of DN 
 
According to the classification received in Russia, the taking after stages of 
DN have currently distinguished: the stage of chronic kidney disease, the stage of 
proteinuria, and the stage of microalbuminuria [37]. 
The stage of microalbuminuria is characterized by the appearance of a small 
amount of albumin in the urine: from 20-199 mcg/min in the morning portion and 
from 30-299 mg in the daily portion, undetectable during routine methods of urine 
testing. At this stage, the patient with DM does not have any clinical symptoms. The 
frequency of MA detection increases with the duration of the disease in both type 1 
and type 2 diabetes [38]. 
The stage of proteinuria is determined by the preserved filtration function of 
the kidneys: urinary albumin excretion of more than 200 mg/min or more than 300 
mg/day, normal GFR. The presence of proteinuria indicates the irreversibility of the 
process and sclerosis of 50-75% of the renal glomeruli [39]. 
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The stage of chronic kidney failure is diagnosed in the presence of pro-
teinuria and increased levels of creatinine and urea in the biochemical analysis of 
blood [40]. 
The diagnosis of diabetic nephropathy currently includes the stage of chronic 
kidney disease, according to the classification approved in 2005 by KDIGO (Kidney 
Disease: Improving Global Outcomes). CKD was divided into 5 stages depending 
on the GFR score calculated using the Cockcroft-Gault, MDRD, and CKD-EPI for-
mulas (table 1).  
 
Table 1 The stage of CKD by levels of estimated GFR 
GFR (ml/min/1,73 m2) Determination  Stage 
≥ 90 High and optimal С1 
60 – 89 Slightly reduced С2 
45 – 59 Moderately reduced С3а 
30 – 44 Significantly reduced С3b 
15 – 29 Sharply reduced С4 
< 15 End-stage renal disease С5 
 
Stage 3 of CKD is divided into 3а («moderately reduced» GFR– 45-59 
ml/min/1,73 m²) and 3b stage («significantly reduced» GFR – 30-44 ml/min/1,73 
m²) [15]. 
 
1.3 The laboratory method for evaluating filtration function of kidneys 
 
There are several methods for evaluating the filtration function of the kid-
neys. To date, there is no method for studying GFR that is perfect in terms of accu-
racy, availability, and usability. The most accurate is the clearance methods. The 
volume of plasma that is completely cleared of any substance in a minute is called 
the clearance of this substance. To assess GFR, the clearance of such substances that 
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enter the urine only by glomerular filtration (not reabsorbed or secreted) is studied. 
In scientific research, GFR is calculated based on the clearance of exogenous sub-
stances that are injected into the blood. They remain the "gold standard" for meas-
uring GFR, but their technical complexity and complexity, the need to inject a for-
eign substance into the blood, and high cost limit their use. 
Glomerular filtration can also be measured by the clearance of endogenous 
substances. This substance can serve as creatinine, which enters the blood from mus-
cle tissue at a roughly constant rate. Due to the fact that creatinine is not reabsorbed 
and is not released in the tubules, it enters the urine only by glomerular filtration, 
and its clearance is equal to the value of glomerular filtration. For its calculation, 
you can use the Rehberg test, which involves measuring the concentration of creat-
inine in plasma, the volume of daily urine, and the concentration of creatinine in the 
urine. 
However, it requires a daily collection of urine, which is performed accord-
ing to strict rules. Incorrect collection of urine and inaccurate measurement volume 
urine lead to significant distortions in the estimation of GFR. 
Mathematical formulas are widely used for indirect estimation of GFR by 
the level of creatinine in the blood. The first was the Cockcroft– Gault formula that 
is enough to use an ordinary calculator. It is simple, but it is desirable to standardize 
the resulting value on the surface of the patient's body, which significantly compli-
cates calculations [41]. When applying the Cockcroft-Gault formula, it should also 
be remembered that it was created to calculate creatinine clearance and does not take 
into account the creatinine channel secretion. 
In the 90s, based on the data from the MDRD study, new equations were 
proposed that are more accurate than the Cockcroft-Gault formula and do not require 
additional standardization on the surface of the body [41]. To calculate using the 
MDRD formula, it is enough to know the serum creatinine level, gender, age, and 
race of the patient. Although the MDRD formula at stages 3-5 of CKD more accu-
rately reflects the function than the Cockcroft-Gault formula, at true GFR above 60 
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ml / min/1.73 m2, it gives understated results. In other words, the main limitation is 
an underestimation of GFR in normal kidney function. 
In 2009-2011, the most universal and accurate method for calculating GFR 
was developed that works at any stage of CKD and in all three races – the CKD-EPI 
equation (collaboration in the epidemiology of chronic kidney disease). 
CKD-EPI quations: 
𝐺𝐹𝑅 (𝑚𝑙/𝑚𝑖𝑛/1,73 𝑚2)  
=  141 ×  [𝑚𝑖𝑛 plasma creatinine(𝑚𝑐𝑚𝑜𝑙/𝑙)/𝑘 или 1]𝛼 × 
×  [𝑚𝑎𝑥 plasma creatinine (𝑚𝑐𝑚𝑜𝑙/𝑙) /𝑘 или 1]−1,209
×  0,993Age ×  1,018 (for female)  
×  1,159 (for members of the black race)  
 
where k – 61,9 for female and 79,6 for male, α – (–0,329) for female and (–0,411) 
for male; creatinine (mcmol/l) = creatinine (md/dl) × 88,4  
The CKD-EPI formula is better correlated with reference methods for deter-
mining GFR [41].  
It is recommended to calculate GFR using the CKD-EPI equations when de-
termining serum creatinine levels in each biochemical laboratory. However, modern 
markers recognize CKD when at least 50-70% of the nephrons in both kidneys are 
affected. 
 
1.4 Method of radionuclide diagnostics  
 
One of the types of radiation diagnostics is radionuclide diagnostics and its 
applications in urology and nephrology have made it able to help studying kidney 
function. Indications for radionuclide studies of kidneys are such diseases as acute 
or chronic renal failure, renal artery stenosis, obstructive uropathy, reflux nephrop-
athy, congenital abnormalities, transplanted kidney, kidney injury or of the kidneys 
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and ureters [44]. 
Significant progress in the field of nuclear medicine, physics and technology 
are associated with the development of single-photon and positron-emission com-
puted tomography, as well as radiopharmaceuticals (RP), which in the body allows 
you to register, capture and study extremely small amounts of radioactive radiation, 
which is practically harmless to the body of the subject. 
Diagnostic RPs are administered to the patient in indicator quantities at 
which the radiation dose is minimal. Scintigraphy images are obtained based on the 
features of inclusion and distribution of RP registered with the help of radio-diag-
nostic equipment and the structural and functional state of the studied organs is eval-
uated depending on the functional state of their cellular system. The intensity of 
radiation from a radioactive indicator is used to quantify their viability or the degree 
of functional impairment, which later allows us to accurately compare studies in 
dynamics [44, 45]. 
Unlike contrast agents used in x-ray studies, isotope-labeled RP do not lead 
to side effects and are not nephrotoxic All isotopes used for radionuclide research 
are short-lived they quickly disintegrate, stopping irradiation, and RP is quickly re-
moved from the body after the study. As a result, the radiation load is significantly 
lower than in radiography and computed tomography. 
Radioisotope diagnostics makes it possible to detect abnormalities of kidney 
function already in the initial stages of the disease when other methods are still un-
informative [46, 41, 42]. 
 
1.4.1 Dynamic renal scintigraphy 
 
The main method of radionuclide study of kidneys is dynamic renal scintig-
raphy which provides an assessment of glomerular filtration, tubular secretion, uro-
dynamics, the state of parenchyma and blood supply to the kidneys, the topography 
of the entire organ and its individual sections. 
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The most well-known RPs for kidney evaluation are 99mTc-DTPA (diethy-
lenetriaminopentaacetic acid), 99mTc –MAG3 (mercaptoacetyltri-glycerol), and 
99mTc-DMSA (3 - dimercaptoyantaric acid) [47, 48]. But in the world practice today, 
99mTc-DTPA is mainly used for assessing kidney filtration. 
The method of measuring gamma camera radiation using 99mTc-DTPA is a 
simple method for determining quantitative indicators: 
1. Тmax – time to peak, the time of maximum accumulation of RP when this 
is the period of time RP from the vessels completely accumulates in the 
renal pelvis; 
2. T1/2 – the half time, this is the time period for the removal of RP from the 
kidneys, which the activity of the drug decreases by 2 times from the 
maximum; 
3. GFR – glomerular filtration rate, reflecting the filtration capacity of the 
kidneys. 
The glomerular filtration rate during the radionuclide study of dynamic renal 
scintigraphy (DRS) was determined using a lattice algorithm, which is calculated 
using the formula [44]:𝐺𝐹𝑅 =
(𝐶𝑙+𝐶𝑟)
𝑃
∙ 100% ∙ 9,975621 − 6,19843, meanwhile  
𝐶𝑙 = 𝐾(2,3)𝑙 ∙ exp (0,153 ∙ 𝐷), 
𝐶𝑟 = 𝐾(2,3)𝑟 ∙ exp (0,153 ∙ 𝐷). 
 
where 𝐾(2,3)𝑙 and 𝐾(2,3)𝑟–the total savings for renographically curve in the in-
terval from 2 to 3 min after the receipt of the drug (area renogram, indirectly reflect-
ing the maximum amount of tracer that passed through the kidney for a specified 
period of time) for the left and right kidneys, respectively; P – the difference in the 
score of the syringe before and after injection; D – the depth of the kidney. 
Separate GFR for left (𝐺𝐹𝑅𝑙) or right (𝐺𝐹𝑅𝑟) kidneys calculate as: 
𝐺𝐹𝑅𝑙 =
𝐶𝑙
𝐶𝑙+𝐶𝑟
 or 𝐺𝐹𝑅𝑟 =
𝐶𝑟
𝐶𝑙+𝐶𝑟
. 
When performing dynamic renal scintigraphy, it is possible to determine the 
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initial changes in kidney function [43]. According to V.N. Slavnov et al., radionu-
clide research methods reveal significant changes in intrarenal hemodynamics and 
filtration-excretory kidney function in patients with type 2 diabetes already at the 
preclinical stages of DN [50]. Changes in the values of the filtration-excretory func-
tion of the kidneys indicate the bilateral nature of kidney damage in DM. Using ra-
dionuclide diagnostics methods, it is possible to determine the localization of the 
pathological process in the parenchyma, calyx, and pelvis of the kidneys, which is 
not always detected during clinical and laboratory examination. 
Even though this method has been used for a long time – it has not lost its 
relevance to the present day, as evidenced by publications of the last decade [ 49, 52, 
53, 54,55, 56, 57, 58]. However, only a small number of studies are devoted to the 
use of the scintigraphy method to assess the functional state of the kidneys in patients 
with type 2 diabetes [60, 59, 61,62]. This method requires less time than other meth-
ods, but the debate about its diagnostic accuracy continues. However, a common 
opinion on the diagnostic value of GFR indicators for various types of renal lesions 
from DM has not yet been formed [63, 64, 60]. 
 
1.5 The conclusion to the literature review 
 
The development and implementation of prevention of DN progression are 
important both for preventing the development of CRF and subsequent dialysis treat-
ment and for reducing the risk of cardiovascular complications since persistent al-
buminuria and reduced GFR are independent risk factors for high cardiovascular 
mortality in patients with DM. It is also important to remember that the prognosis of 
patients with DN is associated not only with a high risk of cardiovascular accidents, 
but also with the progression of other complications of DM: proliferative retinopathy, 
Autonomous, and peripheral neuropathy, diabetic foot syndrome, and largely de-
pends on the timely diagnosis of this complication and correct treatment tactics at 
different stages [42]. 
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Solving the problems of the diagnostic methods can help reduce the number 
of kidney transplants, which will reduce the socio-economic burden on society and 
improve the quality of life of patients  
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Chapter 2. Materials and methods of research 
 
2.1 Design of research 
 
A total of 91 patients admitted to the clinic for examination and treatment in 
the endocrinology clinic of the SSMU were studied, including: 48 patients with type 
1 diabetes and 43 patients with type 2 diabetes in the period from 2015 to 2019. 
All patients were examined according to modern diagnostic standards. They 
were given a clinical examination and follow-up, a resolution of the DM based on 
WHO criteria (1999), urine analysis for albuminuria (normoalbuminuria, microal-
buminuria, proteinuria), determination of biochemical blood analysis (determination 
of creatinine, urea), including the level of glycated hemoglobin (HbA1c), radionu-
clide studies (DRS on the Philips BrightView gamma camera) were performed to 
calculate GFR renal function, maximum accumulation (Tmax) and its half-time (T1/2) 
of RP. 
When analyzing each clinical observation of patients, various complaints 
were identified, information about kidney diseases was considered, attention was 
paid to the stage of the disease, as well as to the existing syndromes and symptoms. 
The master's thesis performed at the department of radiation diagnostics and 
radiation therapy the Federal State Budgetary Educational Institution of Higher pro-
fessional education "Siberian State Medical University" in the Ministry of Health 
the Russian Federation, c. Tomsk, the scientific adviser is head of the department of 
radiation diagnostics and radiation therapy V.D. Zavadovskaya (doctor medical sci-
ence, professor), deputy chief doctor of clinics М.А.Zorkal’tsev (doctor medical sci-
ence). 
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2.2 Object of research 
 
The characteristics of patients by gender and age are presented in table 2. 
The average age of patients with type 1 diabetes was 38.1 ±2.1 years, women 
predominated. 
The average age of patients with type 2 diabetes was 61.1 ±1.4 years, men 
predominated. 
Criteria for inclusion in the study group of patients with type 1 diabetes: 
1. Absence of symptomatic arterial hypertension; 
2. Age of the subjects is 18 years and older; 
3. Consent patients for participation in ongoing research. 
Criteria for exclusion from the study group of patients with type 1 diabetes: 
1. Severe concomitant pathology (metastatic lesion, stage 4-5 CKD); 
2. Viral hepatitis; 
3. Pregnancy; 
4. Voluntary refusal of patients to participate in the study. 
Criteria for inclusion in the study group of patients with type 2 diabetes: 
1. Control of hypertension; 
2. Presence of a persistent increase in glucose levels; 
3. Subjects aged 18 years or older; 
4. Consent patients for participation in ongoing research. 
Criteria for exclusion from the study group of patients with type 2 diabetes: 
1. Viral hepatitis; 
2. Presence of uncontrolled arterial hypertension; 
3. Severe concomitant pathology (metastatic lesion, stage 4-5 CPN); 
4. Pregnancy; 
5. Voluntary refusal of patients to participate in the study. 
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Table 2 – Age and gender composition of the study groups 
Characteristics  
Patients (n=91) 
n % 
Sex 
Female with DM 1 25 27,5 
Male with DM 1 18 19,8 
Female with DM 2 23 25,3 
Male with DM 2 25 27,4 
Av. age of patients 
DM 1 
38,1 ±2,1 years 43 47,2 
Av. age of patients 
DM 2 
61,1 ± 1,4 years 48 52,8 
 
In table 2, all patients were divided by age and gender under types of DM. 
Group of type 1 diabetes consisted of 18 men and 25 women aged 18 to 56 years 
(average age 38.1 ±2.1 years) and group of type 2 diabetes consisted of 25 men and 
23 women aged 19 to 72 years (average age 61.1 ± 1.4 years). 
 
Table 3 – Age-gender composition in the group of type 1 diabetes at various stages 
of diabetic nephropathy 
Parameters Statistic 
NA 
(n=13) 
MA 
(n=5) 
PO 
(n=2) 
Age 
Ме 
(Q1–Q3) 
37 
(33−43) 
35 
(26−36) 
21 
− 
Duration of DM 1 type  
Ме 
(Q1–Q3) 
19 
(13−25) 
16 
(12 – 18) 
15 
(12−18) 
Sex 
m 
N 
(%) 
4 
(30,8 %) 
4 
(80,0%) 
1 
(50,0%) 
f 
9 
(69,2%) 
1 
(20,0%) 
1 
(50,0%) 
HbA1c, % M±SE 8,0±0,6 8,5±1,5 12,5±2,6 
Notes: M – average value; SE-standard error of the average; Me-median; Q1–Q3-quartiles (lower 
and upper); N (%) – number of people; p – level of statistical significance. 
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According to the revealed DN in patients with type 1 diabetes, patients were 
divided into the groups by the stage of normoalbuminuria (13 people), 
microalbuminuria (5 people) and proteinuria (2 people) shown in table 3. For the 
diagnosis of preclinical stages of diabetic nephropathy, urine analysis for 
microalbuminuria was used. Quantitative determination of albuminuria was 
performed by enzyme immunoassay using kits from ORGenTec Diagnostika. 
The average age of DN patients with type 1 diabetes was 37 (33-43) years, 
in the 2nd – 35 (26-36) years, and in the third – 21 years. Patients of all three 
subgroups had different disease history (type 1 diabetes experience decreased from 
the NA subgroup to the PO subgroup), which is a consequence of the atypical course 
of diabetes before the onset of pronounced morphfunctional changes in the renal 
parenchyma. In the stage of NA, MA, The Hbalc level was 8.0±0.6% and 8.5±1.5 
%, which indicates the decompensation of carbohydrate metabolism. Individuals in 
the PO group have marked decompensation of carbohydrate metabolism. If the 
difference available and would glycated hemoglobin less than 1.5% decompensation 
was seen as reasonable if the difference is more than 1.5% as severe. 
 
Table 4 – Age-gender composition in the group of type 2 diabetes at various stages 
of diabetic nephropathy 
 
 
 
Parameters Statistic 
NA 
(n=20) 
MA 
(n=11) 
PO 
(n=3) 
Age 
Ме 
(Q1–Q3) 
64 
(59,5−70,3) 
58 
(54−60) 
56 
(56−62,5) 
Duration of DM 2 
type 
Ме 
(Q1–Q3) 
17 
(12,8−18,8) 
9 
(8−16) 
21 
(16−26,5) 
Sex 
m  
N 
(%) 
6 
(30,0%) 
5 
(45,5%) 
3 
(100%) 
f  
14 
(70,0%) 
6 
(54,5 %) 
0 
(0%) 
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Continuation of table 4 
Notes: M – average value; SE-standard error of the average; Me-median; Q1–Q3-quartiles (lower 
and upper); N (%) – number of people; p – level of statistical significance. 
 
And patients with type 2 diabetes were divided into the groups by the stages 
of normoalbuminuria (20 people), microalbuminuria (11 people), and proteinuria (3 
people) shown in table 4. In which the average age in patients with DN with type 2 
diabetes was 64 (59.5 – 70.3) years, in the 2nd -58 (54-60) years and in the third-56 
(56-62,5) years. Patients of all three subgroups had different disease history (type 2 
diabetes increased from the NA subgroup to the PO subgroup), which is a conse-
quence of the typical course of diabetes before the onset of pronounced morphofunc-
tional changes in the renal parenchyma. As in the subgroups of the norm - and mi-
croalbuminuria, the female sex prevailed over the male. In the stage of NA, PO, the 
HbAlc level was 8.0±1.4% and 8.3±1.8 %, which indicates the decompensation of 
carbohydrate metabolism. In individuals of the MA group, there is a marked decom-
pensation of carbohydrate metabolism, which is the first mechanism of progression 
of kidney failure. 
 
Research methods: 
− Clinical and laboratory research methods; 
− Instrumental radiation research methods. 
Equipments:  
− Calorimeters KvK-3; 
− Goryaev's Camera; 
− ORGenTec Diagnostica; 
− SPECT Philips BrightView. 
 
HbA1c, % M±SE 8,0±1,4 10,4±2,4 8,3±1,8 
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2.3 Clinical and laboratory research methods 
 
Laboratory tests were performed in the clinical and diagnostic laboratory of 
the clinics of SSMU of the Ministry of the health of Russia. General urine analysis 
was performed using a unified method using colorimetric analysis on the colorimeter 
KvK-3, the specific weight of urine was measured using a hydrometer (durometer) 
with a scale range of 0.001-1.050. the Color, transparency of urine, the presence of 
sediment was evaluated visually. The pH of the urine was determined by a methylene 
blue indicator. The uniform elements were counted by Goryaev's camera. 
Biochemical methods consisted of the determination of generally accepted 
indicators, including the determination of liver transaminases, glucose, creatinine, 
urea, and bilirubin. 
The creatinine level was determined using the Popper method based on the 
Jaffe reaction. The urea level was determined by an enzymatic urease method using 
glutamate dehydrogenase as a catalyst. Reference values of creatinine and urea were 
the norms accepted by manufacturers of biochemical kits, taking into account age 
changes. 
Quantitative determination of microalbuminuria was performed by enzyme 
immunoassay using kits from ORGenTec Diagnostika. 
Then the true GFR in ml / min / 1, 73m2 was calculated using the reduction 
of GFR obtained by the formula CKD-EPI. The stage of chronic kidney disease 
(CKD) was determined using the GFR index in patients according to the recommen-
dations of the NKF K/DOQI (national initiative for quality of kidney disease out-
comes of the national kidney Foundation) [49]. 
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2.4 Instrumental radiation research methods 
 
Dynamic renal scintigraphy (DRS) performs on a two-detector gamma cam-
era (SPECT) Philips BrightView with using RP 99mTc-pentatech Russian analog 
99mTc-DTPA (fabricated Ltd «DIAMED», Russia). 
All patients were instructed in advance about the procedure. Preparation for 
the study included preliminary hydration (0.5 liters of water half an hour before the 
study) and emptying the bladder immediately before the study. Radiopharmaceutical 
(99mTc- pentatech) was administered intravenously at a dose of 74-111 MBq in the 
patient's supine position. Before and after the injection, the activity of the indicator 
in the syringe was recorded for 1 minute for subsequent calculation of GFR. 
After the injecting of the RP, data was recorded in 1 frame/sec mode for 1 
min to obtain angiograms, then the study was recorded in 2 frames/min mode for 20 
minutes. In the course of the study, a series of scintigrams with images of the kidneys 
were obtained at various time intervals. 
The data obtained during the DRS was processed using a software package 
on the Philips Medical system "JetStream Work-space 3.0" workstation and in-
cluded: 
- visual image analysis, 
- building and analysis of angioscintigrams, 
–building activity-time curves, the estimation of time and amplitude character-
istics of renogram as indicators of filtration and excretory functions of the kidneys 
with the timing of maximum accumulation of the indicator (Tmax) and half-life (T1/2), 
the remainder of RP for 20-minute research, the contribution to filtration and deter-
mination of glomerular filtration rate (overall and separately for the left and right 
kidney normalized to the surface area of body 1.73m2). 
The result of renal scintigraphy is a series of scintigrams with images of the 
kidneys in different time intervals. Using native scintigraphy, we selected zones of 
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interest from the area of both kidneys, heart, and background, which were used to 
plot the "activity-time" curves (figure 1). 
 
 
Figure 1 – Results of dynamic renal scintigraphy 
 
2.5 Statistical processing of the material 
 
The results of the study were processed in a special software STATISTICA-6 
[65]. At the first stage of quantitative data analysis, the distribution law was checked 
using the Mann – Whitney test. Data obeying the normal distribution law were de-
scribed using the mean and standard error of the mean. Quantitative data that do not 
follow the normal distribution law were described using median and quartiles. The 
choice of the method of comparison of the studied groups was also determined by 
the law of data distribution. Data obeying the normal distribution law were compared 
using the student's t-test. To assess the linear dependence of quantitative data, the 
Spearman coefficient (r) was calculated. The correlation was considered strong, with 
a coefficient value greater than 0.7 and less than -0.7; from 0.5 to 0.7 and from -0.5 
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to -0.7, the correlation was considered average; the correlation was considered weak, 
with a coefficient value less than 0.5 and more than -0.5. When the significance level 
of p is less than 0.05, it was assumed that the studied indicator in the compared 
groups had statistically significant differences.  
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Chapter 3. Results of research 
 
3.1 Evaluation of dynamic renal scintigraphy parameters 
 
The purpose of this section is to study the diagnostic capabilities of the dy-
namic renal scintigraphy method in identifying reliable parameters of DRS in pa-
tients DN with different types of DM. 
At the first stage of the research in this section, the analysis of the relation-
ship between clinical and laboratory data and the parameters of the DRS radionu-
clide study was performed. The obtained monitor values of GFR, Tmax, and T1/2 were 
used for comparison with clinical and laboratory data. In the study groups, the GFR 
level fluctuated within 26~140 ml/min, the maximum accumulation time of the Tmax 
indicator fluctuated within 0.5 ~ 15.5 minutes, and the half-time of the T1/2 indicator 
varied within 0 ~ 100 minutes. 
When comparing the results of the daily protein level in urine, the volume of 
urine and the level of MA with the parameters of the DRS radionuclide study, no 
data were obtained on the presence of statistically significant correlations between 
the studied indicators, the data are shown below in tables 5, 6 and 7. 
  
Table 5 – Searching results for the relationship between the level of daily protein in 
the urine and the main parameters of DRS 
Parameters 
Correlation co-
efficient, r 
Student’s cri-
teria, t 
Level of statistical 
significance, p 
GFR 
total 0,008 0,054 0,956 
left 0,027 0,171 0,864 
right 0,023 0,144 0,886 
Тmax 
left -0,004 -0,027 0,977 
right 0,028 0,178 0,859 
T1/2 left 0,200 1,296 0,202 
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Continuation of table 5 
 right -0,099 -0,629 0,532 
 
Table 5 shows a statistically insignificant correlation between the level of 
daily protein in the urine, in which the GFR for the left kidney was r=0.027 
(p=0.864), which differs slightly from the GFR for the right kidney and for the Gen-
eral, and is very weak and unreliable.  
In the half-life of RP, there is a similar dynamic on the part of the kidneys. 
However, in the time of maximum accumulation of RP, the values for the right kid-
ney were higher than for the left. 
 
Table 6 – Searching results for the relationship between the volume urine and the 
main parameters of DRS 
Parameters 
Correlation co-
efficient, r 
Student’s cri-
teria, t 
Level of statistical 
significance, p 
GFR 
total 0,174 1,063 0,295 
left 0,135 0,809 0,424 
right 0,144 0,860 0,396 
Тmax 
left -0,129 -0,760 0,452 
right 0,059 0,352 0,727 
T1/2 
left 0,092 0,547 0,588 
right -0,002 -0,011 0,991 
 
In this table, no statistically significant correlation was obtained by volume 
in the urine. The values of the total GFR were r=0.174 (p=0.295), which is slightly 
different from the GFR for the right kidney and for total, and are weak and unreliable 
In the half-time and the time of maximum accumulation of RP, a similar 
dynamic was observed on the part of the kidneys. 
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Table 7 – Searching results for the relationship between the level of microalbumi-
nuria and the main parameters of DRS 
Parameters 
Correlation co-
efficient, r 
Student’s cri-
teria, t 
Level of statistical 
significance, p 
GFR 
total -0,197 -1,449 0,153 
left -0,179 -1,303 0,198 
right -0,281 -2,067 0,043 
Тmax 
left -0,070 -0,499 0,620 
right -0,177 -1,269 0,210 
T1/2 
left 0,265 1,961 0,055 
right 0,008 0,055 0,956 
 
According to the results of table 7, a statistically insignificant correlation was 
obtained for the level of MA, in which the GFR for the left kidney is r= -0.179 
(p=0.198), which differs in the direction of a slight decrease from the value of the 
total GFR and is weak and not reliable. However, the level of MA and GFR in the 
right kidney has a level of static significance p=0.043, but the correlation coefficient 
is very weak r= - 0.281. 
In the half-time period of RP, there is also a level of static significance 
p=0.055 and is reliable, but the correlation coefficient is very weak r=0.265. the 
Values of the maximum accumulation time of RP for the right kidneys are higher 
than for the left kidneys. 
At the same time, there is a statistically significant correlation between cre-
atinine levels and total GFR (figure 2), as well as separate GFR for the left and right 
kidneys. The weak and medium level of correlation is consistent with the data on the 
influence of various pathological processes on the creatinine level that are not di-
rectly related to the filtration function of the kidneys in table 8. 
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Table 8 – Searching results for the relationship between the creatinine and the main 
parameters of DRS 
Parameters 
Correlation co-
efficient, r 
Student’s cri-
teria, t 
Level of statistical 
significance, p 
GFR 
total -0,609 -5,480 0,000001 
left -0,491 -3,988 0,000217 
right -0,582 -5,016 0,000007 
Тmax 
left -0,023 -0,162 0,872 
right -0,210 -1,506 0,138 
T1/2 
left 0,243 1,770 0,083 
right 0,123 0,874 0,386 
 
Special attention should be paid to the fact that there is no static relationship 
between such an indicator of renal filtration function as Tmax and creatinine level, 
which indicates its limited use at the current level of diagnosis. 
Also noteworthy is the lack of a reliable relationship between the level of 
creatinine and radionuclide indicators of excretory kidney function T1/2. On the left 
excretory kidney, the significance level almost reached a reliable p=0.083.  
42 
39,0
63,0
78,2
93,0
110,0
132,0
164,0
180,0
214,6
creatinine
26
37
46
55
65
73
83
91
99
108
117
134
to
ta
l G
F
R
Figure 2.  Comparison of total GFR for creatinine 
  
When searching for the relationship between the age of patients and radio-
nuclide indicators of GFR, attention was drawn to the presence of an average inverse 
correlation between the studied indicators with an absolute level of static signifi-
cance Age did not correlate with data on excretory kidney function. On the left kid-
neys T1/2, there is a high level of static significance p=0.019 with a weak correlation 
coefficient r = 0.276. 
 
Table 9 – Searching results for the relationship between age of patients and the main 
parameters of DRS 
Parameters 
Correlation co-
efficient, r 
Student’s cri-
teria, t 
Level of statistical 
significance, p 
GFR total -0,626 -6,709 0 
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Continuation of table 9 
 
left -0,608 -6,363 0 
right -0,504 -4,808 0,000009 
Тmax 
left 0,103 0,855 0,396 
right -0,105 -0,876 0,384 
T1/2 
left 0,276 2,396 0,019 
right 0,165 1,400 0,166 
 
According to table 9, the average inverse correlation with GFR indicators 
demonstrates how kidney function decreases depending on the patient's lifetime.  
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Figure 3  Comparison of total GFR for age of patients 
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However, the duration of the disease and the results of radionuclide assess-
ment of kidney function were not interrelated, which may be due to the effectiveness 
of the therapy. 
There was also no correlation between the level of glycated hemoglobin and 
the results of radionuclide research. That is, glycated hemoglobin does not affect the 
kidney directly, due to the fact that it is the main initiating metabolic factor in the 
development of diabetic kidney damage. 
 
Table 10 – Searching results for the relationship between duration of DM and the 
main parameters of DRS 
Parameters Correlation co-
efficient, r 
Student’s cri-
teria, t 
Level of statistical 
significance, p 
GFR total -0,039 -0,330 0,742 
left -0,082 -0,679 0,499 
right -0,095 -0,783 0,437 
Тmax  left -0,025 -0,203 0,839 
right -0,125 -1,034 0,303 
T1/2 left 0,103 0,864 0,391 
right 0,146 1,223 0,226 
 
According to table 10, in general, the inverse correlation of the GFR rela-
tionship was found to be very weak for both the total and the divided (right and left 
kidney) with an unreliable level of significance. 
According to the time of maximum accumulation of RP for the right kidney, 
the level of significance is more significant than the left one with weak correlation 
relationships. 
According to the data of excretory kidney function, the values for both kid-
neys did not differ significantly, also with a weak correlation relationship. 
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Table 11 – Searching results for the relationship between glycated hemoglobin and 
the main parameters of DRS 
Parameters 
Correlation co-
efficient, r 
Student’s cri-
teria, t 
Level of statistical 
significance, p 
GFR 
total -0,065 -0,539 0,592 
left 0,002 0,018 0,985 
right -0,064 -0,533 0,596 
Тmax 
left 0,022 0,183 0,855 
right -0,240 -2,043 0,045 
T1/2 
left 0,049 0,408 0,685 
right -0,132 -1,111 0,270 
 
According to table 11, a statistically insignificant correlation was obtained 
for HbA1c glycerol hemoglobin, in which the GFR for the left and right kidneys was 
r= -0.065 (p=0.592) and r= -0.064 (p=0.596), respectively, and differs in the direc-
tion of insignificant entrainment from the GFR value for the left kidney and are weak 
and incomplete. 
According to the time of maximum accumulation of RP for the right kidney, 
there is a reliable level of static significance p= 0.45 with a weak inverse correlation. 
According to the data of excretory kidney function, the values for both kid-
neys did not differ significantly, also with a weak correlation relationship. 
Further, we compared the total glomerular filtration rate of a radiopharma-
ceutical against types of diabetes mellitus. Special attention should be paid to the 
influence of the type of diabetes on the indicators of kidney function. 
In a pairwise comparison, there is a statistically significant difference be-
tween the type of diabetes and the level of total GFR (figure 4). 
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Figure 4 – Indicators of the total glomerular filtration rate of a radiopharmaceutical 
(total GFR) for type DM (1 and 2) according to dynamic renal scintigraphy 
 
At the same time, the median values of total GFR in patients with type 2 
diabetes are lower than in type 1 diabetes and are 68.5 and 94.0 ml / min/ 1.73 m2, 
respectively (table 10). And this difference is due to the greater severity of the pro-
gression of renal failure (inflammation of the interstitial tissue with a decrease in the 
tone of the pelvicalyceal system).   
It can be assumed that the delayed evacuation of the radiopharmaceutical 
from the calico-pelvic system is based on the inflammatory infiltration of interstitial 
tissue with a decrease in the tone of the calico-pelvic system of the kidneys. Inflam-
mation is one of the main factors contributing to the development of diabetes com-
plications. 
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Table 12 – Indicators of the total glomerular filtration rate in the kidneys depending 
on the types of diabetes according to dynamic renal scintigraphy 
№ Type of DM n 
Total GFR 
Ме (Q1–Q3) 
Level of statistical 
significance, p 
1 1 type 43 94 (83.0-108.0) 
p1-2<0,001 
2 2 type 48 68.5 (47.5-85.5) 
Notes: Me – median; Q1–Q3 – quartile (lower and upper); р – level of statistical significance. 
 
Thus, the DRS reflects the main pathological changes in the kidneys in pa-
tients with diabetes mellitus. At the same time, more attention should be paid to the 
GFR indicator in terms of reliability, in contrast to Tmax and T1/2, which did not show 
themselves to be reliable indicators in all comparisons. 
 
3.2 Building an algorithm based on the result 
 
According to results, the confidence parameters for the diagnosis of kidneys 
in patients with diabetes mellitus is the glomerular filtration rate in comparison with 
others. But other parameters give no less important information about the state of 
the kidneys, such as vascular diseases, reflux, and retention in the renal pelvis. 
When constructing the screening algorithm, risk factors for chronic kidney 
disease and cardiovascular disease in patients with diabetes mellitus were taken into 
account. 
Although albuminuria was not correlated and was not static when looking 
for a relationship with GFR. It is an important risk factor for cardiovascular disease. 
The value of the phenotype as a marker of nephropathy progression changed after 
demonstrating that a significant proportion regressed to normal albumin excretion 
(normoalbuminuria) in both type 1 and type 2 diabetes mellitus [34, 68]. This is due 
to the filtration capacity of the kidneys of different ages of patients with different 
stages of renal insufficiency on the background of diabetes mellitus.  
48 
Thus, GFR and Albuminuria are indeed associated with renal and cardiovas-
cular diseases in people with diabetes. 
For the early diagnosis of kidney damage or prevention of the development 
of chronic kidney disease, we have provided a single diagnostic guide for various 
types of DM with DN, and the algorithm is shown in figure 5. 
 
 
 
Figure 5 – Algorithm for evaluating kidney function in people with diabetes 
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Chapter 4. Financial management, resource efficiency, and resource-
saving 
 
Research master's thesis is a scientific work related to scientific research, 
conducting research in order to obtain scientific generalizations, finding principles, 
and ways to create (modernize) products. 
Currently, the prospect scientific research isn't determined to scale of the 
discovery that in the early stages of the life cycle of high-tech and the resource-
efficient product is hard enough to reach. Therefore, commercial value is as im-
portant as development research. 
Evaluation of the commercial value (potential) of the development is a nec-
essary condition when searching for sources of funding for scientific research and 
commercialization of its results. The commercial value is essential for developers 
who need to understand the state and prospects of ongoing research. 
The purpose of this Chapter is to determine the prospects and success of a 
scientific research project, develop a mechanism for managing and supporting spe-
cific project solutions at the implementation stage. 
Currently, the demand for new technologies in the diagnosis of various dis-
eases is significantly increasing. The largest markets for the production of these tech-
nologies are GE, Siemens, Toshiba, Philips, which is directly related to the state 
interest in this area, as well as the quality of treatment in clinics where those tech-
nologies used. But the above companies are world-class companies, and therefore 
the target group of consumers includes medical centers and hospitals, the terms of 
use of which are undoubtedly dictated by people who diagnose with diseases of var-
ious etiologies. 
 
4.1 Ishikawa diagram 
 
Ishikawa diagram (also called fishbone diagrams, herringbone diagrams, 
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cause-and-effect diagrams, or Fishikaw) is a graphical method for analyzing and 
forming a cause-effect link, a tool for systematically determining the causes of the 
problem and subsequent visual representation. 
Scope of the diagram: 
– Identify the causes of the problem; 
– Analysis and structuring of processes in the enterprise; 
– Assessment of cause-and-effect links. 
Figure 6 shows the use of the Ishikawa scheme (one of the seven classical 
methods for analyzing the quality management system), which allows you to iden-
tify and to group the conditions and factors that affect the process of making a diag-
nosis in a patient, and analyze the cause-and-effect link (a means of object decom-
position) in this process. 
Diagnostic tests performed in all patients to establish a clinical diagnosis in-
clude central and concomitant diseases. As a rule, this diagnostic mechanism in-
cludes medical examinations, blood and urine tests, a minimum list of biochemical 
indicators, taking into account compliance with the requirements for the standard of 
medical care –quality indicators for significant diseases. 
The list of diagnostic and therapeutic measures for the patient must be sci-
entifically justified. 
Medical care measures should define at all the main stages of treatment and 
the location of the disease. Indications for additional methods of diagnosis and treat-
ment should be clearly and shortly formulated. It is necessary to include the mini-
mum clinical information for decision-making and choice of tactics. 
It is vital to use the Ishikawa scheme to reduce document flow, eliminate 
duplication of information and its concentration. Using this scheme for a rational 
consultation algorithm in the process of diagnosis will avoid repetitions in the ex-
amination. So, we are reducing the personal time of both the attending doctor and 
consultants, improve contact with the patient (his relatives) and, most importantly, 
carry out an objective assessment and analysis of the work of various employees.  
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Figure 6 – Cause-and-effect diagrams during the diagnosis process 
 
4.2 SWOT analysis 
 
Complex analysis solution with the greatest competitiveness is carried out 
with the method of the SWOT analysis: Strengths, Weaknesses, Opportunities and 
Threats. SWOT analysis is used to study the external and internal environment of 
the project (Table 13) 
The analysis has several stages. The first stage consists of describing the 
strengths and weaknesses of the project, identifying opportunities and threats to the 
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project that have emerged or may appear in its external environment. The second 
stage consists of identifying the compatibility of the strengths and weaknesses of the 
project with the external environmental conditions. This compatibility or incompat-
ibility should help to identify what strategic changes are needed.  
An interpretation of each of these concepts: 
1. Strengths are factors that characterize the competitive side of a research 
project. Strengths indicate that the project has a distinctive advantage or special re-
sources that are special in terms of competition. In other words, strengths are re-
sources or capabilities which is available to the project management that can be ef-
fectively used to achieve the goals set. At the same time, it is important to consider 
the strengths both side from the point of view of the project management and who 
involved in it. 
2. Weaknesses are a lack, omission, or limitation of a scientific research pro-
ject that hinder the achievement of its goals. This is something that does not work 
well within the project or where it has insufficient capabilities or resources compared 
to competitors. 
3. Opportunities include any preferred situation in the present or future that 
occurs in the project environment, such as a trend, change, or perceived need that 
supports the demand for project results and allows the project management to im-
prove its competitive position. 
4. A threat is any undesirable situation, trend or change in the project envi-
ronment that is disruptive or threatening to its competitiveness in the present or fu-
ture. A threat can be a barrier, restriction, or anything else that can cause problems, 
destruction, harm, or damage to the project. To identify project threats, we recom-
mend answering the following questions: 
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Table 13 – SWOT analysis 
 
Strengths: 
S1. The important advantages 
of the procedure include accu-
racy and speed. Scintigraphy is 
also highly informative: it al-
lows not only to exclude or 
confirm the disease, but also, if 
the diagnosis is confirmed, to 
obtain qualitative and quantita-
tive data on the localization, 
size, and extent of damage to 
the structures of the body at the 
earliest stages. 
S2. Technetium is foreign to 
human biochemistry, so it does 
not interfere in any way with 
metabolic processes and is 
completely eliminated from the 
body without causing harm 
S3. The cost of conducting re-
search is lower than other types 
due to the simplicity of the 
method and the low cost of the 
technology. 
S4. The damage caused by ra-
dioactive substances is mini-
mal, much lower compared to 
computed tomography 
Weaknesses: 
W1. The absence of hybrid 
technology. 
W2. It is contraindicated to 
conduct an examination of 
pregnant and nursing 
women, as well as children. 
W3. Possible allergic reac-
tions. 
Opportunities: 
O1. The use of the infrastruc-
ture of Siberian State Medi-
cal University 
O2. The use of the infrastruc-
ture of The Scientific Re-
search Institute of Cardiol-
ogy 
O3. Optimization of master's 
degree programs in the spe-
cialists of " Nuclear medi-
cine» 
Results for the interactive ma-
trix of the project «Strengths 
and Opportunities»: 
1) Development of new 
RP with a shorter half-
life and lower radiation 
load to reduce the nega-
tive effects of ionizing 
radiation on patients. 
2) Development of a 
methodological guide 
to improving the pro-
cess training of special-
ists in the sphere of nu-
clear medicine. 
 
Results for the interactive 
matrix of the project «Weak-
nesses and Opportunities»: 
1) The possibility of 
combining radiation 
hybrid technology 
due to the develop-
ment of additional 
software for the best 
results. 
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Continuation of table 13 
Threats: 
T1. Absence of funding from 
the state and private organi-
zations 
T2. Threat of gamma camera 
failure 
T3. Threat of electronic 
computer failure 
T4. Delays in delivery of the 
RP generators  
Results for the interactive ma-
trix of the project «Strengths and 
Threats»: 
1) Publication of the ob-
tained data in the scien-
tific community. 
2) A strategy to reduce 
threats through timely 
maintenance and instal-
lation of modern soft-
ware. 
Results for the interactive ma-
trix of the project «Weak-
nesses and Threats»: 
1) Getting research 
grants. 
2) Development of new 
methods and proto-
cols for medical 
equipment. 
3) Professional develop-
ment of staff 
 
The results of SWOT analysis are taken into account when developing the 
structure of work performed within the framework of a research project. 
 
4.3 Project Initiation 
 
The initiation process group consists of processes that are performed to de-
fine a new project or a new phase of an existing one. In the initiation processes, the 
initial purpose and content are determined and the initial financial resources are 
fixed. The internal and external stakeholders of the project who will interact and 
influence the overall result of the research project are determined. This information 
is provided in the Project Charter. 
The Project Charter documents the business needs, current understanding of 
the project customer's needs, and a new product, service, or result that is planned to 
be created. 
Charter research project master's thesis the following structure: 
1. The purpose and results of the project. This section provides information 
about project stakeholders, the hierarchy of project purposes, and criteria for achiev-
ing purposes. 
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Project stakeholders are defined as individuals or organizations that are ac-
tively involved in the project or whose interests may be affected either positively or 
negatively during the execution or completion of the project (Table 14). 
 
Table 14 – Stakeholders of the project 
Project stakeholders Stakeholder expectations 
Medical institutions (scientific re-
search institutes, laboratories, univer-
sities) 
–The results of the research allow us to expand 
the existing possibilities of radionuclide re-
search methods in the assessment of renal in-
sufficiency against diabetes mellitus, to give a 
comprehensive assessment of the state of the 
calyx-pelvis and urinary system in this cate-
gory of patients. 
SI TPU 
–Development of bilateral relations with partner 
universities in the sphere of nuclear medicine. 
–Publications in international and national jour-
nals, conferences to improve the quality rating 
of the University, citation index 
 
Table 15 provides information about the hierarchy of project purposes and crite-
ria for achieving goals. 
 
Table 15 – Purpose and results of the project 
Purpose of project: 
Improving radiological diagnostics of 
kidney condition in patients with dia-
betic nephropathy and diabetes mellitus 
using renal scintigraphy. 
Expected results of the project: 
The obtained data significantly comple-
ment and expand the existing capabili-
ties of radionuclide research methods 
(SPECT/CT) in assessing the severity of 
diabetic nephropathy (DN) against the 
background of diabetes mellitus (DM); 
The revealed features of renal disorders 
indicate the need for early scintigraphy 
examination of patients with clinical 
manifestations of these types of patholo-
gies. 
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Continuation of table 15 
Criteria for acceptance of the project result: 
For the first time, a comprehensive com-
parative clinical and instrumental  
assessment of the state of the calico-pel-
vic system in patients with DN in DM; 
The role of renal scintigraphy in deter-
mining the severity of General and re-
gional lesions in patients with DN on the 
background of DM is argued, and crite-
ria for assessing the severity of this con-
dition based on the results of radionu-
clide methods are developed. 
Requirements for the project result: 
To study the nature and severity of kid-
ney function using scintigraphy in pa-
tients with diabetic nephropathy  
(DN) for DM; 
Development of a method for calculat-
ing glomerular filtration rate in patients 
using radionuclide studies 
To evaluate in a comparative aspect the 
features (degree of reduction) of GFR in 
DN patients with type 1 and type 2 dia-
betes. 
 
2. The organizational structure of the project. It is necessary to solve some 
questions: who will be part of the working group of this project, determine the role 
of each participant in this project, and prescribe the functions of the participants and 
their number of labor hours in the project. This information is represented in table 
form (Table 16). 
 
Table 16 – Project workgroup 
№ Participant Role in the project Functions 
Labor time, 
hours. 
1 Zavadovskaya V.D. Supervisor 
Project activity control-
ling 
2460 
2 Zorkal’tsev M.A. Head of Division 
Controlling the activities 
of the division's staff 
3450 
3 Udodov V.M Radiologist  Doctor Conducting research 1010 
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4 Kudaibergen G.B. Medical Physicist Processing of results 4480 
Total: 11 400 
 
3. Project limitations and assumptions. Project limitations are all factors that 
can be as a restriction on the degree of freedom of the project team members. This 
information is represented in table 17. 
 
Table 17 – Project limitations 
Factors Limitations / Assumptions 
Project's budget 405 711,1 rub 
Source of financing State budget 
Project timeline: 2 years 
Date of approval of plan of project November 2018  
Completion date June 2020 
 
4.4 Project plan 
 
As part of planning a science project, you need to build a project timeline 
and a Gantt Chart. The schedule is presented in table 18. 
 
Table 18 – Project Schedule (working days) 
Job title 
Duration, 
working 
days 
Start date 
Date of com-
pletion 
Participants 
Preparation of technical 
specifications and 
choice of research direc-
tion 
41 
November 
1, 2018. 
December 28, 
2018. 
Radiologist Doc-
tor/Supervisor 
Selection and study of 
materials on the topic 
198 
January 9, 
2019. 
December 27, 
2019. 
Medical Physicist  
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Continuation of table 18 
Calendar planning of 
work on the topic 
345 
November 
1, 2018. 
June 7, 2020. Head of Division 
Development of a Gen-
eral research methodol-
ogy 
60 
March 1, 
2019. 
May 31, 
2019. 
Radiologist Doc-
tor/Medical Physicist 
Obtaining the necessary 
experimental data and 
checking the results 
205 
June 1, 
2019 
March 
27,2020. 
Supervisor/Medical 
Physicist 
Processing the received 
data 
140 
September 
2, 2019. 
March 27, 
2019. 
Medical Physicist 
Writing a master's the-
sis 
96 
December 
2, 2020. 
May 29, 
2020. 
Medical Physicist 
Master's thesis defense 14 
June 1, 
2020. 
June 19, 
2020. 
Medical Physicist 
 
4.5 Formation budget costs 
 
When planning the budget of scientific research, it should be provided with 
a complete and reliable reflection of all types of planned expenditures necessary for 
its implementation. In the process of budgeting, planned expenditures are grouped 
by the items, which are shown in table 19. 
 
Table 19 – Items expenses grouping 
Items 
Name 
Material 
costs 
Costs of 
special 
equipment 
Basic 
salary 
Additional 
salary 
Deductions 
on social 
needs 
Overhead Total cost 
Cost, 
rubles 
405789 1022725 3580383 537058 1235232 139200 6920310 
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Material costs of scientific and technical research 
In this article are included the cost of purchasing all types of materials, com-
ponents and semi-finished products necessary for the execution of works on the sub-
ject. The amount of required material values is determined by the consumption rate 
in the amount of 91 patients 
 
Table 20 – Raw materials, supplies, purchased products, and semi-finished products 
Name Mark, size 
Quantity, 
pc 
Price per unit, rub. Sum, rub. 
Syringes 19G, 20ml 91 18 1638 
Gloves L 91 2,7 245,7 
Masks AMC-Med 91 4,4 400,4 
RP Generator 
Generator Tech-
netium-99m  
4 96000 384000 
Cups 
FLO ART. 
18/20, 
6 PS 
91 2 182 
For materials 386466 
Transport and purchasing expenses (3-5%) 405789 
Total by item  405789 
 
Special equipment for scientific (experimental) work 
This article includes all costs associated with the purchase of special equip-
ment (devices, instrumentation, stands, devices and mechanisms) necessary for car-
rying out work on a specific topic. The cost of special equipment is determined ac-
cording to the current price lists, and in some cases at the contract price (table 21). 
 
Table 21 –  Calculating costs by item «Special equipment for scientific work» 
Name of the equip-
ment 
Number of equip-
ment units 
The price of the equip-
ment, M. rub. 
Total cost of equip-
ment, M. rub. 
Philips BrightView 1 27M. rub. 27M. rub. 
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The cost of equipment used in the implementation of a specific scientific 
project and available in this scientific and technical organization is taken into ac-
count in the form of depreciation charges: 
𝐶 = 27𝑀. 𝑟𝑢𝑏. 
𝐴 =
100%
11
= 9,09% 𝑝𝑒𝑟 𝑦𝑒𝑎𝑟 
∑ 𝐴 =
27 ∙ 9,09
100
= 2,45𝑀. 𝑟𝑢𝑏. 𝑝𝑒𝑟 𝑦𝑒𝑎𝑟 
𝐴𝑚 =
2,45
12
= 204545𝑟𝑢𝑏. 𝑝𝑒𝑟 𝑚𝑜𝑛𝑡ℎ  
𝐴𝑚.𝑗 = 204545 ∙ 5 = 1022725 𝑟𝑢𝑏 
where A – amortization rate, %; 
 ∑A – the sum of amortization, rub. per year; 
 Am – the sum of amortization, rub per month; 
 Am.j – the sum of amortization for the period of scientific research work , rub. 
 
Basic salary 
This article includes the basic salary of scientific and engineering workers, 
workers of layout workshops and experimental productions directly involved in the 
performance of work on this topic. The amount of salary expenses is determined 
based on the labor intensity of the work performed and the current system of remu-
neration. The basic salary includes a bonus paid monthly from the salary Fund (the 
amount is determined by the Regulations on remuneration). 
The item includes the basic salary of employees directly involved in the pro-
ject (including bonuses, surcharges) and additional wages: 
𝐶𝑠 = 𝑆𝑏𝑎𝑠𝑖𝑐 + 𝑆𝑎𝑑𝑑 
where: 
Sbasic – basic salary; 
Sadd – additional salary. 
The basic salary (Sbasic) of the head (laboratory assistant, engineer) from the 
enterprise (if there is a head from the enterprise) is calculated by the following for-
mula: 
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𝑆𝑏𝑎𝑠𝑖𝑐 = 𝑆𝑎𝑣 ∙ Т𝑤 
where: 
Sbasic– basic salary per employee; 
Тw– the duaration of the work performed by the scientific and technical 
worker, working days; 
Sav– the average daily salary of an employee, rub. 
The average daily salary is calculated by the formula: 
𝑆𝑎𝑣 =
𝑆𝑚 ∙ М
𝐹𝑣
 
where: 
Sm – monthly salary of an employee, rub; 
М – the number of work months without vacation for a year:  
–at holiday in 24 working days. М =11,2 months, 5 days per week;  
–at holidayе in 48 working days, М=10,4 months, 6 days per week; 
Fv– valid annual Fund of working hours of scientific and technical person-
nel, working days (table 22). 
 
Table 22 – Working time balance for working group of the project  
Parameters  Working group of the project 
Calendar number of days 365 
The number of non-working days  
-weekend 
-holidays 
 
104 
14 
Loss of working time 
-vacation 
-absences due to illness 
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Valid annual working time (Fv) 195 
Monthly salary of an employee: 
𝑆𝑚 = 𝑆𝑏 ∙ (𝑘𝑝𝑟 + 𝑘𝑏) ∙ 𝑘𝑑 
where: 
Sb – base salary, rub.; 
kpr –premium coefficient;  
kb – bonus coefficient; 
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kd – district coefficient, equals 1,3 (for Tomsk).  
Calculation for salaries are on table. 23 
 
Table 23 – Calculation of salaries  
Executors Sb, rub kpr kb kd Sm,rub Sav, rub. 
Тw, 
working 
days. 
 
Sbasic, 
rub. 
Supervisor 50000 
0,3 1,28 1,3 
102700 5477 246 1347342 
Head of Divi-
sion 
30000 61620 3286 345 1133670 
Radiologist 
Doctor  
20000 41080 2191 101 221291 
Medical physi-
cist 
17890 36746 1960 448 878080 
 
Additional salary of research and production personnel  
This article includes the amount of payments stipulated by the legislation on 
labor, for example, payment of regular and additional holidays; payment of time 
associated with the performance of state and public duties; remuneration of service, 
etc. (on average - 12% of the amount of the basic salary). 
Additional salary is calculated on the basis of 10-15% of the basic salary, 
workers directly involved in the implementation of the topic 
𝑆𝑎𝑑𝑑 = 𝑘𝑎𝑑𝑑 ∙ 𝑆𝑏𝑎𝑠𝑖𝑐 
where: 
Sadd – additional salary, rub.; 
kadd– additional salary coefficient; 
Sbasic – basic salary, rub. 
There are calculations for salaries in table 24. 
 
Table 24 – Salary calculation  
Salary Supervisor Head of Division 
Radiologist 
doctor 
Medical physi-
cist 
Basic salary 1347342 1133670 221291 878080 
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Continuation of table 24 
Additional salary 202101 170051 33194 131712 
Salary of maker 1549443 1303721 254485 1 009792 
Total CS 4117441 
 
Deductions for social needs. 
This item includes deductions to extra-budgetary funds (table 25) 
𝐶𝑒𝑥 = 𝑘𝑒𝑥 ∙ (𝑆𝑏𝑎𝑠𝑖𝑐 + 𝑆𝑎𝑑𝑑) = 𝑘𝑒𝑥 ∙ 𝐶𝑠 
where kex – coefficient of deductions for payment to extra-budgetary funds (pen-
sion fund, compulsory medical insurance fund, etc.), equal 0,3. 
 
Table 25 – Deductions for social needs 
Name Sum 
Salary of maker of a supervisor, rub. 1549443 
Coefficient of deductions 0,3 
Sum of the supervisor's deductions, rub. 464833 
Sum of the head of division's deductions, rub. 391116 
Sum of the radiologist doctor's deductions, rub. 76346 
Sum of the medical physicist's deductions, rub. 302937 
Total 1235232 
 
Overhead costs 
Overhead costs include other management and maintenance costs that can 
be allocated directly to the project. In addition, this includes expenses for the mainte-
nance, operation and repair of equipment, production tools and equipment, build-
ings, structures, etc. 
Overhead costs account from 30% to 90% of the amount of base and addi-
tional salary of employees. 
Overhead is calculated according to the formula: 
𝐶 = 𝑇𝑒𝑙 ∙ 𝑃 ∙ 𝑡𝑒𝑞 
where: 
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Tel –tariff for electricity (5,8 rub per 1 kW*h); 
P – equipment capacity kW; 
teq – equipment usage time, h. 
Electricity costs were 139200 rub. 
 
Table 26 – Electricity costs 
Name Measure unit 
Number 
of days 
Working hours 
per day for 
equipment, 
hour 
Price per 
unit, rub. 
Electricity 
costs, rub. 
Electricity kW*h 240 10 5,8 139200 
Total: 139200 
 
4.6 Project risk register   
 
The identified risks of the project include possible uncertain events that 
may occur in the project and cause consequences that will entail undesirable ef-
fects. All information is in table 27. 
 
Table 27 – Risk register 
№ Risk 
Poten-
tial im-
pact 
Probabil-
ity of oc-
currence 
(1 - 5) 
Influ-
ence  
(1 - 5) 
Level 
of 
risk 
Ways 
to miti-
gate 
risk 
Condition 
of occur-
rence 
1 
Failure 
of 
gamma 
camera 
Suspen-
sion of 
the radi-
oisotope 
diagnos-
tics 
3 5 High 
Regular 
mainte-
nance 
and 
quality 
control 
Absence of 
quality con-
trol and 
mainte-
nance 
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Continuation of table 27 
2 
A failure 
in the 
supply 
of the 
RP gen-
erator 
Suspen-
sion of 
the radio-
isotope 
diagnos-
tics 
2 5 High Absent 
Failure of 
the nuclear 
reactor; ab-
sence of fuel 
for the air-
craft; termi-
nation of the 
license for 
the produc-
tion of gen-
erators 
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Chapter 5. Social responsibility 
 
5.1 Introduction 
 
This section discusses issues related to safety in the workplace, its rules of 
operation in the event of possible dangerous situations. 
In the final qualifying work, the task was to develop renal scintigraphy cri-
teria for affected kidneys using radionuclide technology (SPECT)in patients with 
diabetic nephropathy with various types of diabetes mellitus. To perform this work, 
a diagnostic device of the SPECT was required, which is currently in the department 
of radionuclide diagnostics of the Federal State Budgetary Educational Institution of 
Higher professional education "Siberian State Medical University" of the Ministry 
of Health of the Russian Federation. And the main part of the work was on pro-
cessing the received images and data on a PC. 
This section will cover dangerous and harmful factors that may arise during 
research, legal and organizational issues, as well as emergency measures. 
 
5.2 Legal and organizational items in providing safety 
 
Nowadays one of the main ways to radical improvement of all prophylactic 
work referred to reduce Total Incidents Rate and occupational morbidity is the wide-
spread implementation of an integrated Occupational Safety and Health manage-
ment system. That means combining isolated activities into a single system of tar-
geted actions at all levels and stages of the production process. 
Occupational safety is a system of legislative, socio-economic, organiza-
tional, technological, hygienic and therapeutic and prophylactic measures and tools 
that ensure the safety, preservation of health and human performance in the work 
process [69]. 
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According to the Labor Code of the Russian Federation, every employee has 
the right: 
- to have a workplace that meets Occupational safety requirements; 
- to have a compulsory social insurance against accidents at manufacturing 
and occupational diseases; 
- to receive reliable information from the employer, relevant government 
bodies and public organizations on conditions and Occupational safety at the work-
place, about the existing risk of damage to health, as well as measures to protect 
against harmful and (or) hazardous factors; 
- to refuse carrying out work in case of danger to his life and health due to 
violation of Occupational safety requirements; 
- be provided with personal and collective protective equipment in compli-
ance with Occupational safety requirements at the expense of the employer; 
- for training in safe work methods and techniques at the expense of the em-
ployer; 
- for personal participation or participation through their representatives in 
consideration of issues related to ensuring safe working conditions in his workplace, 
and in the investigation of the accident with him at work or occupational disease; 
- for extraordinary medical examination in accordance with medical recom-
mendations with preservation of his place of work (position) and secondary earnings 
during the passage of the specified medical examination; 
- for warranties and compensation established in accordance with this Code, 
collective agreement, agreement, local regulatory an act, an employment contract, if 
he is engaged in work with harmful and (or) hazardous working conditions. 
The labor code of the Russian Federation states that normal working hours 
may not exceed 40 hours per week, the employer must keep track of the time worked 
by each employee. 
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Rules for labor protection and safety measures are introduced in order to pre-
vent accidents, ensure safe working conditions for workers and are mandatory for 
workers, managers, engineers and technicians. 
 
5.3 Basic ergonomic requirements for the correct location and ar-
rangement of researcher’s workplace 
 
The workplace when working with a PC should be at least 6 square meters. 
The legroom should correspond to the following parameters: the legroom height is 
at least 600 mm, the seat distance to the lower edge of the working surface is at 
least 150 mm, and the seat height is 420 mm. It is worth noting that the height of 
the table should depend on the growth of the operator. 
The following requirements are also provided for the organization of the 
workplace of the PC user: The design of the working chair should ensure the 
maintenance of a rational working posture while working on the PC and allow the 
posture to be changed in order to reduce the static tension of the neck and shoulder 
muscles and back to prevent the development of fatigue. 
The type of working chair should be selected taking into account the 
growth of the user, the nature and duration of work with the PC. The working chair 
should be lifting and swivel, adjustable in height and angle of inclination of the 
seat and back, as well as the distance of the back from the front edge of the seat, 
while the adjustment of each parameter should be independent, easy to carry out 
and have a secure fit. 
 
5.4  Occupational safety 
 
A dangerous factor or industrial hazard is a factor whose impact under cer-
tain conditions leads to trauma or other sudden, severe deterioration of health of the 
worker [69]. 
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A harmful factor or industrial health hazard is a factor, the effect of which 
on a worker under certain conditions leads to a disease or a decrease in working 
capacity. 
 
5.4.1 Analysis of harmful and dangerous factors that can create object 
of investigation  
 
The object of the study is "diagnostics of kidneys by radionuclide diagnostics 
in the SPECT devices". Therefore, the object of research of dangerous and harmful 
factors has, during the work, you need to observe safety regulations. In addition, you 
need to do a lot of work on processing the received images on a PC. 
 
5.4.2. Analysis of harmful and dangerous factors that can arise at 
workplace during investigation 
 
The working conditions in the workplace are characterized by the presence 
of hazardous and harmful factors, which are classified by groups of elements: 
physical, chemical, biological, psychophysiological. The main elements of the pro-
duction process that form dangerous and harmful factors are presented in Table 28. 
 
Table 28 – Possible hazardous and harmful factors 
Factors 
(GOST 
12.0.003-
2015) 
Work stages 
Legal 
documents Development Manufacture Exploitation 
1. Deviation 
of 
microclimate 
indicators 
+ + + 
Sanitary rules 
2.2.2 / 2.4.1340–
03.  
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Continuation of table 28 
2. Excessive 
noise 
 + + 
Sanitary and epide-
miological rules and 
regulations "Hy-
gienic requirements 
for personal elec-
tronic computers 
and work organiza-
tion." 
Sanitary rules 2.2.1 
/ 2.1.1.1278–03. 
Hygienic require-
ments for natural, 
artificial and com-
bined lighting of 
residential and pub-
lic buildings. 
Sanitary rules 2.2.4 
/ 2.1.8.562–96. 
Noise at work-
places, in premises 
of residential, public 
buildings and in the 
construction area. 
Sanitary rules 
2.2.4.548–96. Hy-
gienic requirements 
for the microclimate 
3.Increased 
level of elec-
tromagnetic 
radiation 
+ + + 
4.Insuffi-
cient illumi-
nation of the 
working area 
 + + 
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of industrial prem-
ises. 
5. Abnor-
mally high 
voltage 
value in the 
circuit, the 
closure 
which may 
occur 
through the 
human body 
+ + + 
Sanitary rules 
GOST 12.1.038-
82 SSBT. Electri-
cal safety. Maxi-
mum permissible 
levels of touch 
voltages and cur-
rents. 
6. Increased 
levels of ion-
izing radia-
tion 
+ + + 
Sanitary Rules 
2.6.1. 2523 -0 9. 
Radiation Safety 
Standards (NRB-
99/2009). 
 
The following factors effect on person working on a computer: 
- physical:  
o temperature and humidity;  
o noise;  
o static electricity;  
o electromagnetic field of low purity; 
o illumination; 
o presence of radiation; 
-  psychophysiological: 
Continuation of table 28 
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o  psychophysiological dangerous and harmful factors are di-
vided into:  
- physical overload (static, dynamic)  
- mental stress (mental overstrain, monotony of work, emo-
tional overload). 
 
Deviation of microclimate indicators 
The air of the working area (microclimate) is determined by the following 
parameters: temperature, relative humidity, air speed. The optimum and permissible 
values of the microclimate characteristics are established in accordance with [70] 
and are given in Table 29. 
To create optimal weather conditions used an air conditioner that maintains 
optimal microclimate parameters automatically, regardless of changing circum-
stances. In the cold season, heating is used to maintain the optimal air temperature 
in the room (table 29). 
 
Table 29 – Optimal and permissible parameters of the microclimate 
Period of the year Temperature, C 
Relative 
humidity,% 
Speed of air 
movement, m/s 
Cold and chang-
ing of seasons 
23-25 40-60 0.1 
Warm 23-25 40 0.1 
 
Excessive noise 
Noise and vibration worsen working conditions, have a harmful effect on the 
human body, namely, the organs of hearing and the whole body through the central 
nervous system. It results in weakened attention, deteriorated memory, decreased 
response, and increased number of errors in work. Noise can be generated by oper-
ating equipment, air conditioning units, daylight illuminating devices, as well as 
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spread from the outside. When working on a PC, the noise level in the workplace 
should not exceed 50 dB. 
 
Increased level of electromagnetic radiation 
The screen and system blocks produce electromagnetic radiation. Its main 
part comes from the system unit and the video cable. According to [70], the intensity 
of the electromagnetic field at a distance of 50 cm around the screen along the elec-
trical component should be no more than: 
- in the frequency range 5 Hz - 2 kHz - 25 V / m; 
- in the frequency range 2 kHz - 400 kHz - 2.5 V / m. 
The magnetic flux density should be no more than: 
- in the frequency range 5 Hz - 2 kHz - 250 nT; 
- in the frequency range 2 kHz - 400 kHz - 25 nT. 
 
Abnormally high voltage value in the circuit 
Depending on the conditions in the room, the risk of electric shock to a per-
son increases or decreases. Do not operate the electronic device in conditions of high 
humidity (relative air humidity exceeds 75% for a long time), high temperature 
(more than 35 ° C), the presence of conductive dust, conductive floors and the pos-
sibility of simultaneous contact with metal components connected to the ground and 
the metal casing of electrical equipment.  
The computer operator works with electrical devices: a computer (display, 
system unit, etc.) and peripheral devices.  
There is a risk of electric shock in the following cases:  
− with direct with current-carrying parts during computer repair; 
− when touching non-current-carrying parts that are energized (in case of 
violation of the insulation of current-carrying parts); 
− when touching the floor or walls that are energized; 
− in case of short-circuit in high-voltage units: power supply unit and display 
scanner unit. 
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Table 30 – Upper limits for values of contact current and voltage 
 Voltage, V Current, mA 
Alternate,  50 Hz 2 0.3 
Alternate,  400 Hz 3 0.4 
Direct 8 1.0 
 
Insufficient illumination of the working area 
Light sources can be both natural and artificial. The natural source of the 
light in the room is the sun, artificial light are lamps. With long work in low illumi-
nation conditions and in violation of other parameters of the illumination, visual 
perception decreases, myopia, eye disease develops, and headaches appear. 
According to the standard, the illumination on the table surface in the area 
of the working document should be 300-500 lux. Lighting should not create glare on 
the surface of the monitor. Illumination of the monitor surface should not be more 
than 300 lux. 
The brightness of the lamps of common light in the area with radiation angles 
from 50 to 90° should be no more than 200 cd/m, the protective angle of the lamps 
should be at least 40°. The safety factor for lamps of common light should be as-
sumed to be 1.4. The ripple coefficient should not exceed 5%. 
 
Increased levels of ionizing radiation 
Ionizing radiation is radiation that could ionize molecules and atoms. This 
effect is widely used in energetics and industry. However, there is health hazard. In 
living tissue, this radiation could damage cells that result in two types of effects. 
Deterministic effects (harmful tissue reactions) due to exposure with high doses and 
stochastic effects due to DNA destruction and mutations (for example, induction of 
cancer). 
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To provide radiation safety with using sources of ionizing radiation one 
must use next principles: 
a) keep individual radiation doses from all radiation sources not higher 
than permissible exposure; 
b) forbid all activity with using radiation sources if profit is low than 
risk of possible hazard; 
c) keep individual radiation doses from all radiation sources as low as 
possible. 
There are two groups of people related to work with radiation: personnel, 
who works with ionizing radiation, and population. 
 
Table 31– The basic dose limits 
Quantity 
Dose limits 
Personnel (group A) Population 
Effective dose 
20 mSv per year in av-
erage during 5 years, 
but not higher than 50 
mSv per year 
1 mSv per year in aver-
age during 5 years, but 
not higher than 5 mSv 
per year 
Equivalent dose per year in 
eye’s lens 
 
150 mSv 15 mSv 
Equivalent dose per year in 
skin 
500 mSv 50 mSv 
Equivalent dose per year in 
hands and feet 
500 mSv 50 mSv 
Effective dose for personnel must not exceed 1000 mSv for 50 years of work-
ing activity, and for population must not exceed 70 mSv for 70 years of life. 
In addition, for women from personnel of age below 45 years there is limit 
of 1 mSv per month of equivalent dose on lower abdomen. During gestation and 
breast feeding women must not work with radiation sources. 
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For students older than 16, who uses radiation sources in study process or 
who is in rooms with increased level of ionizing radiation, dose limits are quarter 
part of dose limits of personnel. 
 
5.4.3 Justification of measures to reduce the levels of exposure to haz-
ardous and harmful factors on the researcher 
 
Deviation of microclimate indicators 
The measures for improving the air environment in the production room in-
clude: the correct organization of ventilation and air conditioning, heating of room. 
Ventilation can be realized naturally and mechanically. In the room, the following 
volumes of outside air must be delivered:  
at least 30 m 3 per hour per person for the volume of the room up to 20 
m 3 per person;  
natural ventilation is allowed for the volume of the room more than 40 
m 3 per person and if there is no emission of harmful substances. 
The heating system must provide sufficient, constant and uniform heating of 
the air. Water heating should be used in rooms with increased requirements for clean 
air.  
The parameters of the microclimate in the laboratory regulated by the central 
heating system, have the following values: humidity 40%, air speed 0.1 m / s, sum-
mer temperature 20-25 ° C, in winter 13-15 ° C. Natural ventilation is provided in 
the laboratory. Air enters and leaves through the cracks, windows, doors. The main 
disadvantage of such ventilation is that the fresh air enters the room without prelim-
inary cleaning and heating. 
 
Excessive noise 
In research audiences, there are various kinds of noises that are generated by 
both internal and external noise sources. The internal sources of noise are working 
77 
equipment, personal computer, printer, ventilation system, as well as computer 
equipment of other engineers in the audience. If the maximum permissible condi-
tions are exceeded, it is sufficient to use sound-absorbing materials in the room 
(sound-absorbing wall and ceiling cladding, window curtains). To reduce the noise 
penetrating outside the premises, install seals around the perimeter of the doors and 
windows. 
 
Increased level of electromagnetic radiation 
There are the following ways to protect against EMF: 
- increase the distance from the source (the screen should be at least 50 cm 
from the user); 
- the use of pre-screen filters, special screens and other personal protective 
equipment. 
When working with a computer, the ionizing radiation source is a display. 
Under the influence of ionizing radiation in the body, there may be a violation of 
normal blood coagulability, an increase in the fragility of blood vessels, a decrease 
in immunity, etc. The dose of irradiation at a distance of 20 cm to the display is 50 
µrem / hr. According to the norms [70], the design of the computer should provide 
the power of the exposure dose of x-rays at any point at a distance of 0.05 m from 
the screen no more than 100 µR / h. 
Fatigue of the organs of vision can be associated with both insufficient illu-
mination and excessive illumination, as well as with the wrong direction of light. 
 
Increased levels of ionizing radiation 
In case of radiation accident, responsible personnel must take all measures 
to restore control of radiation sources and reduce to minimum radiation doses, num-
ber of irradiated persons, radioactive pollution of the environment, economic and 
social losses caused with radioactive pollution. 
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Radiation control is a main part of radiation safety and radiation protection.  
It is aimed at not exceeding the established basic dose limits and permissible levels 
of radiation, obtaining the necessary information to optimize protection and making 
decisions about interference in the case of radiation accidents, contamination of the 
environment and buildings with radionuclides. 
The radiation control is control of: 
 Radiation characteristics of radiation sources, pollution in air, liquid 
and solid wastes. 
 Radiation factors developed with technological processes in working 
places and environment. 
 Radiation factors of contaminated environment. 
 Irradiation dose levels of personnel and population. 
The main controlled parameters are: 
 Annual effective and equivalent doses intake and body content of ra-
dionuclides  
 volume or specific activity of radionuclides in air, water, food prod-
ucts, building materials and etc. 
 radioactive contamination of skin, clothes, footwear, working places 
and etc. 
 dose and power of external irradiation. 
 particles and photons flux density. 
Radiation protection office establish control levels of all controlled parame-
ters in according to not exceed dose limits and keep dose levels as low as possible. 
In case of exceeding control levels radiation protection officers start investigation of 
exceed causes and take actions to eliminate this exceeding. 
During planning and implementation of radiation safety precautions, taking 
any actions about radiation safety and analysis of effectiveness of mentioned action 
and precautions one must value radiation safety with next factors: 
 characteristics of radioactive contamination of the environment; 
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 probability of radiation accidents and scale of accidents; 
 degree of readiness to effective elimination of radiation accidents and its 
aftermathches;  
 number of persons irradiated with doses higher than controlled limits of 
doses; 
 analysis of actions for providing radiation safety, meeting requirements, 
rules, standards of radiation safety; 
 analysis of irradiation doses obtained by groups of population from all 
ionizing radiation sources. 
 
Abnormally high voltage value in the circuit 
The mechanical action of current on the body is the cause of electrical inju-
ries. Typical types of electric injuries are burns, electric signs, skin metallization, 
tissue tears, dislocations of joints and bone fractures. 
The following protective equipment can be used as measures to ensure the 
safety of working with electrical equipment: 
- disconnection of voltage from live parts, on which or near to which work will 
be carried out, and taking measures to ensure the impossibility of applying volt-
age to the workplace; 
- posting of posters indicating the place of work; 
- electrical grounding of the housings of all installations through a neutral wire; 
- coating of metal surfaces of tools with reliable insulation; 
- inaccessibility of current-carrying parts of equipment (the conclusion in the 
case of electroporation elements, the conclusion in the body of current-carrying 
parts) [71]. 
 
Insufficient illumination of the working area 
Desktops should be placed in such a way that the monitors are oriented side-
ways to the light openings, so that natural light falls mainly on the left. 
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Also, as a means of protection to minimize the impact of the factor, local 
lighting should be installed due to insufficient lighting, window openings should be 
equipped with adjustable devices such as blinds, curtains, external visors, etc. 
 
5.5 Ecological safety 
 
5.5.1 Analysis of the impact of the research object on the environment 
 
Sources of ionizing radiation used in medicine could be divided into two 
groups: radioactive substances and radiation generators. The difference is that radi-
ation generators like accelerators and x-ray tubes emit ionizing radiation only when 
they are turned on.   
In ordinary work with necessary safety precautions, there are insignificant 
impact of using sources of ionizing radiation on environment. The immediate effect 
of ionizing radiation is ionization of air in room, but after a specified time the ioni-
zation disappears. 
The danger of using radioactive materials could occur only in accidents with 
stealing and loosing these materials due to high toxicity. 
 
5.5.2 Analysis of the environmental impact of the research process 
 
Process of investigation itself in the thesis do not have essential effect on en-
vironment. One of hazardous waste is fluorescent lamps. Mercury in fluorescent 
lamps is a hazardous substance and its improper disposal greatly poisons the envi-
ronment. 
Outdated devices go to an enterprise that has the right to process wastes. It is 
possible to isolate precious metals with a purity in the range of 99.95–99.99% from 
computer components. A closed production cycle consists of the following stages: 
primary sorting of equipment; the allocation of precious, ferrous and non-ferrous 
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metals and other materials; melting; refining and processing of metals. Thus, there 
is an effective disposal of computer devices. 
 
5.5.3 Justification of environmental protection measures 
 
Pollution reduction is possible due to the improvement of devices that pro-
duces electricity, the use of more economical and efficient technologies, the use of 
new methods for generating electricity and the introduction of modern methods and 
methods for cleaning and neutralizing industrial waste. In addition, this problem 
should be solved by efficient and economical use of electricity by consumers them-
selves. This is the use of more economical devices, as well as efficient regimes of 
these devices. This also includes compliance with production discipline in the frame-
work of the proper use of electricity. 
Simple conclusion is that it is necessary to strive to reduce energy consump-
tion, to develop and implement systems with low energy consumption. In modern 
computers, modes with reduced power consumption during long-term idle are 
widely used. 
 
5.6 Safety in emergency 
 
5.6.1 Analysis of probable emergencies that may occur at the work-
place during research 
 
The fire is the most probable emergency in our life. Possible causes of fire: 
- malfunction of current-carrying parts of installations; 
- work with open electrical equipment; 
- short circuits in the power supply; 
- non-compliance with fire safety regulations; 
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- presence of combustible components: documents, doors, tables, 
cable insulation, etc. 
Activities on fire prevention are divided into: organizational, technical, op-
erational and regime. 
 
5.6.2 Substantiation of measures for the prevention of emergencies and 
the development of procedures in case of emergencies 
 
Organizational measures provide for correct operation of equipment, proper 
maintenance of buildings and territories, fire instruction for workers and employees, 
training of production personnel for fire safety rules, issuing instructions, posters, 
and the existence of an evacuation plan [72]. 
The technical measures include compliance with fire regulations, norms for 
the design of buildings, the installation of electrical wires and equipment, heating, 
ventilation, lighting, the correct placement of equipment. 
The regime measures include the establishment of rules for the organization 
of work, and compliance with fire-fighting measures. To prevent fire from short cir-
cuits, overloads, etc., the following fire safety rules must be observed: 
- elimination of the formation of a flammable environment (sealing equip-
ment, control of the air, working and emergency ventilation); 
- use in the construction and decoration of buildings of non-combustible 
or difficultly combustible materials; 
- the correct operation of the equipment (proper inclusion of equipment in 
the electrical supply network, monitoring of heating equipment); 
- correct maintenance of buildings and territories (exclusion of the source 
of ignition - prevention of spontaneous combustion of substances, re-
striction of fireworks); 
- training of production personnel in fire safety rules; 
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- the publication of instructions, posters, the existence of an evacuation 
plan; 
- compliance with fire regulations, norms in the design of buildings, in the 
organization of electrical wires and equipment, heating, ventilation, 
lighting; 
- the correct placement of equipment; 
- well-time preventive inspection, repair and testing of equipment. 
In the case of an emergency, it is necessary to: 
1. inform the management (duty officer); 
2. call the Emergency Service or the Ministry of Emergency Situations - 
tel. 112; 
3. take measures to eliminate the accident in accordance with the instruc-
tions. 
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 Conclusion 
 
This Master's thesis is the first to investigate the possibilities of the method 
of dynamic renal scintigraphy in determining the nature of kidney disarranges in 
patients with diabetic nephropathy with diabetes mellitus 
To develop scintigraphy criteria for evaluating the functional state of the kid-
neys based on radionuclide technology (SPECT) in patients with diabetic nephrop-
athy with diabetes mellitus, the confidential relationship between the parameters of 
the device and clinical and laboratory data was studied and differences in patients 
were evaluated. 
Solving a complex set of problems in the diagnosis of diabetic nephropathy 
in diabetes mellitus should reduce the socio-economic burden on the population of 
various countries and significantly improve the quality of life of patients. 
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Inferences 
 
1. Dynamic renal scintigraphy reflects the main pathological changes in the 
kidneys in patients with diabetes mellitus. 
2. At the same time, the doctor should pay attention to the values of the GFR 
indicator in terms of reliability, in contrast to Tmax and T1/2, which did not show 
themselves as reliable indicators in all comparisons. 
3. Static significant inversely correlated relationship between the total glo-
merular filtration rate and separate for the left and right kidneys with indicators of 
clinical and laboratory data reflects the development of chronic renal failure in pa-
tients with diabetes mellitus. 
4. Decreasing glomerular filtration rate in patients of both groups is due to 
the reaction of the pelvicalyceal system, which compensates for the violation of pro-
tein metabolism. 
5. Compensatory capabilities in patients with type 2 diabetes in combination 
with type 1 diabetes pathology are more pronounced in hyperfiltration, and may even 
be absent in some patients. 
6. Dynamic renal scintigraphy can be used in the algorithm of radiation di-
agnostics of kidney condition in patients with type 1 and 2 diabetes 
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